Search clinical trials for: Androgen insensitive prostate cancer
Total 87885 results
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
MacroGenicsActive, not recruitingMelanoma | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Malignant Melanoma | Non-small Cell Carcinoma | Oral Squamous Cell Carcinoma | Small Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck | Castration-Resistant... and other conditionsSpain, Australia, United States, Korea, Republic of, France, United Kingdom, Italy, Belgium, Poland
-
DendreonCompletedHormone Refractory Prostate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States
-
Bavarian NordicCompletedAndrogen-insensitive Prostate CancerUnited States
-
Stanford UniversityTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Queen's Medical CenterNational Institutes of Health (NIH)CompletedProstate CancerUnited States
-
Sandy SrinivasWyeth is now a wholly owned subsidiary of Pfizer; American Society of Clinical... and other collaboratorsTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
DendreonCompletedProstate CancerUnited States, Canada
-
Qian QinJanssen, LP; UT Southwestern Comprehensive Cancer CenterNot yet recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | BRIP1 Gene Mutation | PALB2 Gene Mutation | CHEK2 Gene Mutation | FANCA Gene Mutation | RAD51B Gene Mutation | RAD54L Gene Mutation | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Deleterious HRR Gene Mutation
-
University of MiamiNot yet recruitingProstate Cancer | Prostate Adenocarcinoma | Hormone Sensitive Prostate CancerUnited States
-
Mayo ClinicNot yet recruitingRecurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage IVB Prostate Cancer AJCC v8 | Recurrent Castration-Sensitive Prostate CarcinomaUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic Prostate Cancer | Therapy, Directly ObservedChina
-
Ohio State University Comprehensive Cancer CenterPfizer; Myovant Sciences GmbH; Sumitomo Pharmaceuticals AmericaNot yet recruitingProstate Adenocarcinoma | Stage IIC Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8United States
-
University College, LondonNovartis; Cancer Research UK; Janssen Pharmaceutica NVNot yet recruiting
-
Pedro Barata, MD, MScESSA Pharma Inc.Not yet recruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-sensitive Prostate Cancer (mHSPC)United States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Recruiting
-
Roswell Park Cancer InstituteRecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Canisius-Wilhelmina HospitalNot yet recruitingProstatic Neoplasms | Metastasis
-
UNICANCERBayerNot yet recruitingProstatic Cancer, Castration-Resistant
-
M.D. Anderson Cancer CenterJanssen Scientific Affairs, LLCNot yet recruitingProstate Cancer | Prostatectomy | Androgen Axis SuppressionUnited States
-
Central Finland Hospital DistrictTampere University; Tampere University Hospital; University of JyvaskylaNot yet recruiting
-
Virginia Commonwealth UniversityNRG OncologyRecruitingProstate CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingMetastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Castration-Sensitive Prostate CarcinomaUnited States
-
Azienda Unità Sanitaria Locale Reggio EmiliaRecruitingRehabilitation | Metastatic Prostate Cancer (PCa) in ADTItaly
-
Canadian Cancer Trials GroupNRG OncologyRecruiting
-
Memorial Sloan Kettering Cancer CenterRecruitingProstate CancerUnited States
-
University of Maryland, BaltimoreJanssen Scientific Affairs, LLCRecruitingProstate Cancer | Oligometastatic DiseaseUnited States
-
Mayo ClinicRecruitingBiochemically Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma | Recurrent Prostate AdenocarcinomaUnited States
-
Haaglanden Medical CentreTata Memorial CentreNot yet recruitingHigh Risk Prostate CarcinomaNetherlands
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic Prostate Cancer | Intermitent Anti-androgen TherapyChina
-
Mamta ParikhNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Advanced Prostate AdenocarcinomaUnited States
-
State University of New York at BuffaloRecruitingProstate CancerUnited States
-
University of ChicagoNot yet recruiting
-
Chinese University of Hong KongRecruitingProstate Cancer | Cardiovascular RiskHong Kong
-
Case Comprehensive Cancer CenterNational Institutes of Health (NIH)Not yet recruitingProstate Cancer | Malignant Neoplasm of Prostate | Secondary Malignant Neoplasm of ProstateUnited States
-
Duke UniversityMemorial Sloan Kettering Cancer Center; University of Wisconsin, MadisonNot yet recruitingProstate Cancer | Castration-resistant Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic
-
University of OklahomaNot yet recruitingAndrogen Deprivation Therapy | Locally Advanced Prostate CancerUnited States
-
University of Kansas Medical CenterNational Cancer Institute (NCI)Not yet recruitingRelugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate CancerStage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8United States
-
University of MiamiVarian Medical SystemsNot yet recruiting
-
Yale UniversityPfizerRecruiting
-
Yale UniversityDendreonRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
VA Office of Research and DevelopmentRecruitingProstate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...United States Department of Defense; Prostate Cancer Foundation; Panbela TherapeuticsRecruitingProstate CancerUnited States
-
University of ArkansasNot yet recruitingCastration Sensitive Prostate CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)RecruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingChemotherapy Effect | Metastatic Prostate Cancer | Hormone Sensitive Prostate CancerChina
-
European Organisation for Research and Treatment...UNICANCER; Spanish Oncology Genito-Urinary Group; Cancer Trials IrelandNot yet recruiting
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)China
-
Novartis PharmaceuticalsRecruitingOligometastatic Prostate Cancer (OMPC)Canada, Israel, Switzerland, Australia, Singapore